Edition:
United States

G1 Therapeutics Inc (GTHX.OQ)

GTHX.OQ on NASDAQ Stock Exchange Global Select Market

19.69USD
16 Feb 2018
Change (% chg)

$-0.41 (-2.04%)
Prev Close
$20.10
Open
$20.00
Day's High
$20.19
Day's Low
$19.04
Volume
19,685
Avg. Vol
47,828
52-wk High
$28.56
52-wk Low
$12.04

Latest Key Developments (Source: Significant Developments)

G1 Therapeutics qtrly ‍loss per share $0.55
Wednesday, 8 Nov 2017 07:30am EST 

Nov 8 (Reuters) - G1 Therapeutics Inc ::G1 therapeutics reports third quarter 2017 financial results and recent operational highlights.G1 therapeutics inc - qtrly ‍loss per share $0.55.G1 therapeutics inc - qtrly loss per share ‍$0.55​.Q3 earnings per share view $-0.55 -- Thomson Reuters I/B/E/S.G1 therapeutics inc- ‍cash, cash equivalents and short-term investments totaled $118.4 million as of sept 30, 2017, versus $47.3 million as of dec 31, 2016​.  Full Article

G1 Therapeutics Inc appoints Barclay (Buck) Phillips as CFO and SVP, corporate development​
Wednesday, 8 Nov 2017 07:00am EST 

Nov 8 (Reuters) - G1 Therapeutics Inc ::G1 Therapeutics Inc - appoints barclay (buck) phillips as chief financial officer and senior vice president, corporate development​.G1 Therapeutics Inc - ‍G1 announced that chief business officer Greg Mossinghoff will depart company in January of 2018​.  Full Article

G1 Therapeutics Q2 loss per share $1.09‍​
Wednesday, 9 Aug 2017 07:30am EDT 

Aug 9 (Reuters) - G1 Therapeutics Inc :G1 Therapeutics reports second quarter 2017 financial results and recent operational highlights.Qtrly loss per share $1.09‍​.Estimates that operating expenses will be in range of $55-$60 million for 2017​.  Full Article

G1 Therapeutics announces closing of initial public offering
Tuesday, 23 May 2017 08:00am EDT 

May 23 (Reuters) - G1 Therapeutics Inc :G1 Therapeutics announces closing of initial public offering.  Full Article

G1 Therapeutics shares open flat from IPO price in debut
Wednesday, 17 May 2017 10:54am EDT 

May 17 (Reuters) - :G1 Therapeutics Inc shares open at $15 in debut on the Nasdaq versus IPO price of $15 per share.  Full Article

G1 Therapeutics announces pricing of initial public offering
Tuesday, 16 May 2017 07:25pm EDT 

May 16 (Reuters) - G1 Therapeutics Inc ::G1 Therapeutics announces pricing of initial public offering.Pricing of its initial public offering of 7 million shares of common stock at a public offering price of $15.00 per share.  Full Article

G1 Therapeutics sees IPO of 6.25 mln shares of commons stock
Monday, 8 May 2017 09:05am EDT 

May 8 (Reuters) - G1 Therapeutics Inc :G1 therapeutics inc sees ipo of 6.25 million shares of its commons stock - sec filing.G1 therapeutics inc - estimated initial public offering price is between $15.00 and $17.00 per share.  Full Article

BRIEF-Medimmune Ventures Sells 133,906 Shares Of G1 Therapeutics Inc's Common Stock On Dec 1

* MEDIMMUNE VENTURES INC REPORTS SALE OF 133,906 SHARES OF G1 THERAPEUTICS INC'S COMMON STOCK ON DEC 1 AT $19.75 PER SHARE - SEC FILING Source text: (http://bit.ly/2iVgOvs) Further company coverage: